HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Aimery de Gramont Selected Research

Fluorouracil (Carac)

12/2012Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial.
9/2012Adjuvant therapy with fluorouracil and oxaliplatin in stage II and elderly patients (between ages 70 and 75 years) with colon cancer: subgroup analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer trial.
6/2012Safety analysis of FOLFOX4 treatment in colorectal cancer patients: a comparison between two Asian studies and four Western studies.
12/2011Defective mismatch repair status as a prognostic biomarker of disease-free survival in stage III colon cancer patients treated with adjuvant FOLFOX chemotherapy.
7/2011Impact of young age on treatment efficacy and safety in advanced colorectal cancer: a pooled analysis of patients from nine first-line phase III chemotherapy trials.
4/2010Comparison of the levogyre and dextro-levogyre forms of leucovorin in a phase III trial of bimonthly LV5FU2 versus monthly 5-fluorouracil and high-dose leucovorin for patients with stage II and III colon cancer (GERCOR C96.1).
1/2010Association between disease-free survival and overall survival when survival is prolonged after recurrence in patients receiving cytotoxic adjuvant therapy for colon cancer: simulations based on the 20,800 patient ACCENT data set.
1/2010Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and FOLFOX response in colorectal cancer patients.
12/2009Can chemotherapy be discontinued in unresectable metastatic colorectal cancer? The GERCOR OPTIMOX2 Study.
7/2009Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $490.00 USD

Aimery de Gramont Research Topics

Disease

38Colorectal Neoplasms (Colorectal Cancer)
09/2014 - 04/2002
28Colonic Neoplasms (Colon Cancer)
01/2014 - 08/2003
19Neoplasms (Cancer)
09/2014 - 06/2003
5Neoplasm Metastasis (Metastasis)
09/2014 - 01/2003
4Neutropenia
12/2012 - 06/2004
4Microsatellite Instability
12/2011 - 01/2004
3Pancreatic Neoplasms (Pancreatic Cancer)
08/2006 - 04/2002
2Carcinoma (Carcinomatosis)
12/2012 - 04/2002
2Nausea
07/2011 - 11/2003
2Ovarian Neoplasms (Ovarian Cancer)
01/2005 - 11/2003
2Stomach Neoplasms (Stomach Cancer)
01/2003 - 04/2002
1Anoxia (Hypoxia)
07/2014
1Hypertension (High Blood Pressure)
12/2012
1Sarcoma (Soft Tissue Sarcoma)
03/2012
1Diarrhea
07/2011
1Fatty Liver
12/2009
1Chromosome Aberrations (Chromosome Abnormalities)
08/2007
1Adenocarcinoma
01/2007
1Renal Cell Carcinoma (Grawitz Tumor)
01/2005
1Hemoptysis
01/2005
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2005
1Breast Neoplasms (Breast Cancer)
01/2005
1Leukopenia
11/2003
1Vomiting
11/2003
1Abdominal Pain (Pain, Abdominal)
11/2003
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
04/2002

Drug/Important Bio-Agent (IBA)

37oxaliplatin (Eloxatin)FDA LinkGeneric
01/2014 - 04/2002
35Fluorouracil (Carac)FDA LinkGeneric
12/2012 - 04/2002
24Leucovorin (Folinic Acid)FDA Link
12/2012 - 04/2002
13irinotecan (Camptosar)FDA LinkGeneric
07/2013 - 04/2002
12bevacizumabFDA Link
07/2014 - 01/2005
9cetuximab (Erbitux)FDA Link
06/2012 - 07/2006
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2014 - 02/2006
6Epidermal Growth Factor Receptor (EGF Receptor)IBA
08/2011 - 05/2005
4capecitabine (Xeloda)FDA Link
07/2013 - 12/2006
3Sodium Glutamate (Accent)IBA
07/2013 - 10/2007
3Monoclonal AntibodiesIBA
10/2011 - 01/2007
3gemcitabineFDA Link
08/2006 - 04/2002
3Cisplatin (Platino)FDA LinkGeneric
11/2003 - 04/2002
2DNA (Deoxyribonucleic Acid)IBA
01/2014 - 10/2011
2Biological Markers (Surrogate Marker)IBA
12/2010 - 05/2010
2Levamisole (Decaris)FDA Link
07/2007 - 06/2004
2Folic Acid (Vitamin M)FDA LinkGeneric
11/2004 - 04/2002
2pemetrexed (MTA)FDA Link
11/2004 - 04/2002
2Hydroxyurea (Hydrea)FDA LinkGeneric
06/2003 - 01/2003
1Immunosuppressive Agents (Immunosuppressants)IBA
09/2014
1PlatinumIBA
12/2013
1UracilIBA
07/2013
1TegafurIBA
07/2013
1XELOXIBA
12/2012
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
03/2012
1panitumumab (Vectibix)FDA Link
10/2010
1Asp(5)- oxytocin (OXA)IBA
01/2010
1Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
01/2010
1chemotactic factor inactivatorIBA
12/2009
1trabectedin (ecteinascidin 743)IBA
08/2007
1Proteins (Proteins, Gene)IBA
08/2007
1Angiogenesis InhibitorsIBA
07/2007
1vatalanib (PTK787)IBA
07/2007
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
07/2007
1Thrombocytopenia chromosome breakageIBA
09/2006
1Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
11/2004
1Epidermal Growth Factor (EGF)IBA
06/2004
1N-methylsuccinimideIBA
01/2004
1Antineoplastic Agents (Antineoplastics)IBA
08/2003
1Carcinoembryonic AntigenIBA
01/2003
1HLFP regimenIBA
01/2003
1AnthracyclinesIBA
04/2002
1Dexamethasone (Maxidex)FDA LinkGeneric
04/2002

Therapy/Procedure

22Drug Therapy (Chemotherapy)
09/2014 - 04/2002
16Adjuvant Chemotherapy
01/2014 - 01/2004
3Heterologous Transplantation (Xenotransplantation)
10/2011 - 06/2003
1Salvage Therapy
03/2012
1Combination Drug Therapy (Combination Chemotherapy)
07/2011
1Complementary Therapies (Alternative Medicine)
11/2007
1Cryotherapy (Therapy, Cold)
01/2004
1Laparotomy
11/2003
1Catheters
11/2003
1Premedication
04/2002